throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`MEDTRONIC, INC.
`Petitioner
`
`v.
`
`NUVASIVE, INC.
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2013-00506
`Patent 8,361,156 
`
`
`
`
`
`
`
`
`
`
`
`
`
`MOTION FOR OBSERVATION REGARDING CROSS-EXAMINATION
`
`OF LOIC JOSSE
`
`

`

`Case IPR2013-00506
`Attorney Docket No: 13958-0116IP2
`
`
`
`
`EXHIBITS
`
`Ex. #
`
`Exhibit Description
`
`NUVA 2101 U.S. Patent No. 7,905,840 to Pimenta et al.
`NUVA 2102 Declaration in Support of the Pro Hac Vice Admission of Michael
`A. Amon; Declaration of Charles Forthaus (Not Filed)
`
`NUVA 2103 Vetebral Spacer-PR Brochure (Not Filed)
`NUVA 2104 Forthaus Memo regarding Vertebral Spacer-PR Brochure (Not
`Filed)
`
`NUVA 2105 myspinetools.com front page (Not Filed)
`
`NUVA 2106 myspinetools.com Terms of Use (Not Filed)
`
`NUVA 2107 Launch Binder (Not Filed)
`
`NUVA 2108 Webpage Toad MySQL (Not Filed)
`
`NUVA 2109 Reserved
`
`NUVA 2010 U.S. Patent 8,512,408 (Hynes) (Not Filed)
`
`NUVA 2011 Synthes SVS-PR Guide
`
`NUVA 2012 Medtronic Sofamor Danek Boomerang brochure
`
`NUVA 2013 Hynes Deposition Transcript
`
`NUVA 2014 510(k) Summary Medtronic Sofamor Danek K122037
`
`NUVA 2015 510(k) Summary Telamon® PEEK Spinal System K110562
`
`NUVA 2016 Synthes Vertebral Spacer – AR Brochure
`
`NUVA 2017 DePuy Spine Saber Surgical Technique Brochure
`
`NUVA 2018 Declaration of Barton L. Sachs, M.D. in IPR2013-00206
`
`2
`
`

`

`Case IPR2013-00506
`Attorney Docket No: 13958-0116IP2
`NUVA 2019 Moro, et al., “An Anatomic Study of the Lumbar Plexus with
`Respect to Retroperitoneal Endoscopic Surgery”
`
`NUVA 2020 Declaration of Dr. Hansen A. Yuan, M.D.
`
`NUVA 2021 Curriculum Vitae of Dr. Hansen A. Yuan, M.D.
`
`NUVA 2022 NuVasive - CoRoent XL Brochure
`
`NUVA 2023 Redacted Engineering Drawings
`
`NUVA 2024 Redacted Deposition of Steven DeRidder
`
`NUVA 2025 Clydesdale® Spinal System Brochure
`
`NUVA 2026 Clydesdale® Spinal System Images
`NUVA 2027 Medtronic Direct Lateral Interbody Fusion DLIF Surgical
`Technique Brochure
`
`NUVA 2028 Medtronic DILF-Direct Lateral Interbody Fusion Brochure
`
`NUVA 2029 Clydesdale® Spinal System Image
`
`NUVA 2030 Declaration of Patrick Miles
`
`NUVA 2031 Declaration of Theodore G. Obenchain, M.D.
`NUVA 2032 The Relationship between Cross Sectional Area and Strength of
`Back Muscles in Patients with Chronic Low Back Pain
`
`NUVA 2033 Printout, U.S. News & World Report
`
`NUVA 2034 Lumbar Vertebral Body Replacement
`
`NUVA 2035 Lumbar – Minimally Invasive Approach (PLIF)
`NUVA 2036 Excerpts from the Mathews Deposition Transcript (non-
`confidential portion)
`
`NUVA 2037 Second Hynes Deposition Transcript
`
`NUVA 2038 Josse Deposition Transcript
`
`3
`
`

`

`Case IPR2013-00506
`Attorney Docket No: 13958-0116IP2
`NUVA 2039 Patent Owner’s Objection to Evidence Under 37 CFR §
`42.64(b)(1), dated 9/12/2014
`
`NUVA 2040 Email from Michael A. Amon to Jeff E. Schwartz, dated 9/9/2014
`
`4
`
`

`

`Case IPR2013-00506
`Attorney Docket No: 13958-0116IP2
`
`
`
`NuVasive, Inc. (“Patent Owner”) submits this motion for observation regarding
`
`cross-examination of Loic Josse, a reply declarant of Medtronic, Inc.
`
`(“Petitioner”). Patent Owner submits the following observations based on Mr.
`
`Josse’s testimony taken on September 23, 2014.
`
`Observation #1
`
`In Ex. 2038, on page 55 lines 13-25, Mr. Josse testified regarding the engineering
`
`drawings that he created, and stated that he did not add black redaction boxes to
`
`the engineering drawings and that the document existed without black boxes at
`
`least in 2013. That testimony is relevant to ¶ 2 of the Josse Declaration (Ex. 1116)
`
`where he references “engineering drawings that I created in January 2000.” The
`
`testimony is relevant because the heavily redacted Appendix A is not a true and
`
`correct copy of the engineering drawings that Mr. Josse actually created.
`
`Observation #2
`
`In Ex. 2038, on page 59, line 20 to page 60, line 11, Mr. Josse testified regarding
`
`an email string that he was copied on, and stated that he did not add black
`
`redaction boxes to the email string and that the document existed without black
`
`boxes at least at least in 2012. That testimony is relevant to ¶ 2 of the Josse
`
`Declaration where he references an “email string, on which I was copied.” The
`
`5
`
`

`

`Case IPR2013-00506
`Attorney Docket No: 13958-0116IP2
`testimony is relevant because the heavily redacted Appendix B is not a true and
`
`correct copy of the email string on which Mr. Josse was actually copied.
`
`Observation #3
`
`In Ex. 2038, page 32, line 7 to page 33, line 18, Mr. Josse testified that his patent
`
`in Appendix E to his Declaration does not state that the implant has a length
`
`exceeding 40 mm. That testimony is relevant to ¶ 4 of the Josse Declaration where
`
`he states that “Medtronic has commercialized interbody spinal fusion implants
`
`having a length of at least 40 mm”. Ex. 1116 at ¶ 4. Nothing in Mr. Josse’s
`
`testimony indicates that the reference teaches a length meeting the claim language
`
`of “greater than 40 mm extending from a proximal end of said proximal wall to a
`
`distal end of said distal wall.” Nothing in Mr. Josse’s testimony indicates that the
`
`reference teaches a length meeting the claim language of “greater than 40 mm
`
`extending from a proximal end of said proximal wall to a distal end of said distal
`
`wall,” much less that any implant greater than 40mm was actually commercialized.
`
`Observation #4
`
`In Ex. 2038, on page 37, line 9 to page 38, line 11, Mr. Josse testified “I don’t have
`
`an opinion. I don’t know.” on whether the brochure in Appendix D to his
`
`declaration discloses an implant exceeding 40 mm. That testimony is relevant to ¶
`
`4 of the Josse Declaration where he states that “Medtronic has commercialized
`
`interbody spinal fusion implants having a length of at least 40 mm”. Ex. 1116 at ¶
`
`6
`
`

`

`Case IPR2013-00506
`Attorney Docket No: 13958-0116IP2
`4. Nothing in Mr. Josse’s testimony indicates that the reference teaches a length
`
`meeting the claim language of “greater than 40 mm extending from a proximal end
`
`of said proximal wall to a distal end of said distal wall,” much less that any implant
`
`greater than 40mm was actually commercialized.
`
`Observation #5
`
`In Ex. 2038, on page 43, lines 6-22, Mr. Josse testified that the implant in the
`
`brochure in Appendix D to his declaration is marked “Not for distribution in the
`
`United States,” “Draft Copy,” and “for internal use only.” That testimony is
`
`relevant to the ¶ 4 of the Josse Declaration where he suggests that the document
`
`was publicly known. The testimony shows that Appendix D was an internal, draft
`
`brochure that is not a public document and not printed prior art.
`
`Observation #6
`
`In Ex. 2038, on page 44, line 16 to page 45, line 17, Mr. Josse testified that he
`
`included no bill of sale for a Butterfly implant, no surgical report for use of a
`
`Butterfly implant in a live patient, and no testimony in his declaration that
`
`indicates that a Butterfly implant was used in the United States. See also Ex. 2038,
`
`Page 43, lines 6-10. That testimony is relevant to the ¶ 4 of the Josse Declaration
`
`where he suggests that the Butterfly implant described in Appendix D was
`
`commercialized. The testimony confirms that there is no evidence of if or when
`
`7
`
`

`

`Case IPR2013-00506
`Attorney Docket No: 13958-0116IP2
`the Butterfly implant was on sale or even used in the United States. See also 35
`
`U.S.C. § 102(b) (Pre-AIA).
`
`Observation #7
`
`In Ex. 2038, on page 73, lines 2-17, Mr. Josse testified to the dimension “D” in
`
`Appendix D as being the “width” of a boomerang implant. That testimony is
`
`relevant because it contradicts Petitioner’s argument in the IPR2013-00507
`
`Petition, p. 21-22 regarding the maximum lateral width of the boomerang implant
`
`in Frey. Specifically, Mr. Josse’s testimony directly contradicts Petitioner’s
`
`assertion that the implant disclosed in Frey meets the claim limitation of “said
`
`longitudinal length [that] is at least two and half times greater than the maximum
`
`lateral width” in claim 1 of the ‘334 patent.
`
`Observation #8
`
`In Ex. 2038, on page 74, line 4 to page 76, line 3, Mr. Josse testified that he has
`
`“no opinion” on whether a boomerang implant with a length of 41 mm and a width
`
`of 18 mm has a maximum length at least 2.5 times greater than the maximum
`
`width. That testimony is relevant to argument in the IPR2013-00507 Petition, p.
`
`21-22 and 52-55 that a boomerang implant should be sized to have a length that is
`
`over 40 mm and that is at least two and half times the maximum lateral width. The
`
`testimony shows that even the unpublished, unused boomerang implant identified
`
`in Appendices A-C to the Josse Declaration does not meet the claim limitation of
`
`8
`
`

`

`Case IPR2013-00506
`Attorney Docket No: 13958-0116IP2
`“said longitudinal length [that] is at least two and half times greater than the
`
`maximum lateral width” in claim 1 of the ‘334 patent. It also calls into question
`
`the credibility of Mr. Josse – a trained engineer who has been designing implants
`
`for the last 20 years – yet was unwilling to answer a simple math problem.
`
`Observation #9
`
`In Ex. 2038, on page 77, line 16 to page 78, line 8, Mr. Josse testified there that
`
`there is no documentation or other evidence, including testimony, that a
`
`confidential prototype boomerang implant of the identified dimensions was ever
`
`actually used in any patient, much less that it was used safely in any patient. That
`
`testimony is relevant to Petitioner’s argument in the IPR2013-00507 Reply, p. 11
`
`that “implants having these expanded dimensions can, and have been made and
`
`implanted using a postero-lateral technique.” The testimony undermines
`
`Petitioner’s Reply argument by confirming the lack of evidence that a boomerang
`
`implant of the identified confidential dimensions was implanted safely or at all, let
`
`alone using a postero-lateral (TLIF) technique.
`
`Observation #10
`
`In Ex. 2038, on page 91, line 7 to page 93, line 8, Mr. Josse testified that his
`
`principal function working for Petitioner Medtronic over the last 20 years has been
`
`designing implants, that he has designed both interbody fusion spacers and
`
`vertebral body replacement devices, but that he has “no opinion” on whether there
`
`9
`
`

`

`Case IPR2013-00506
`Attorney Docket No: 13958-0116IP2
`is a difference between an interbody fusion spacer and a vertebral body
`
`replacement. That testimony again calls into question Mr. Josse’s credibility
`
`because he was unwilling to answer questions regarding the differences between
`
`vertebral body replacements and interbody fusion implants despite his twenty years
`
`of experience designing both.
`
`
`
`
`
`
`Date: 10/6/2014
`
`
`Customer Number 26171
`Fish & Richardson P.C.
`Telephone: (612) 337-2508
`Facsimile: (612) 288-9696
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
` /Stuart A. Nelson/
`Stuart A. Nelson
`Reg. No. 63,947
`
`
`
`10
`
`

`

`Case IPR2013-00506
`Attorney Docket No: 13958-0116IP2
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.6(e)(4)(iii), the undersigned
`
`certifies that on October 6, 2014, a complete and entire copy of this Motion for
`
`Observation Regarding Cross-Examination of Loic Josse was provided via email to
`
`the Petitioner by serving the email correspondence address of record as follows:
`
`Jeff E. Schwartz
`Seth A. Kramer
`Fox Rothschild LLP
`1030 15th Street, NW
`Washington, DC 20005
`
`Email: jeschwartz@foxrothschild.com
`Email: skramer@foxrothschild.com
`Email: ipdocket@foxrothschild.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /Diana Bradley/
`Diana Bradley
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
` (858) 678-5667
`
`
`
`11
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket